Review of the anticancer activities of bee products

Asian Pacific Journal of Tropical Biomedicine

Volumn 4, Issue 5, 2014, Pages 337-344

  Premratanachai, Pongsathon ^a   Chanchao, Chanpen ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Bee products; Cancer cells; Chrysin; Flavonoid; Inflammatory; Propolis

Indexed keywords

BEE VENOM; PROPOLIS; ROYAL JELLY;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CANCER INHIBITION; CELL DEATH; CYTOTOXICITY; HEPATOCELLULAR CARCINOMA CELL LINE; HONEY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; LIVER CANCER CELL LINE; LUNG CANCER CELL LINE; MELANOMA CELL LINE; MITOSIS; NONHUMAN;

APOIDEA;

EID: 84922833124     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.12980/APJTB.4.2014C1262     Document Type: Article

References (103)

1. Oldroyd BP, Wongsiri S. Asian honey bees: biology, conservation and human interactions. Massachusetts: Harvard University Press; 2006.
2. Pyrzynska K, Biesaga M. Analysis of phenolic acids and flavonoids in honey. TrAC Trends Anal Chem 2009; 28: 893-902.
3. Feas X, Vazquez-Tato MP, Estevinho L, Seijas JA, Iglesias A. Organic bee pollen: botanical origin, nutritional value, bioactive compounds, antioxidant activity and microbiological quality. Molecules 2012; 17: 8359-8377.
4. Wieckiewicz W, Miernik M, Wieckiewicz M, Morawiec T. Does propolis help to maintain oral health? Evid Based Complement Alternat Med 2013; 2013: 351062.
5. Terada Y, Narukawa M, Watanabe T. Specific hydroxy fatty acids in royal jelly activate TRPA1. J Agric Food Chem 2011; 59: 2627-2635.
6. Iurlina MO, Saiz AI, Fritz R, Manrique GD. Major flavonoids of Argentinean honey. Optimisation of extraction method and analysis of their content in relationship to the geographical source of honeys. Food Chem 2009; 115: 1141-1149.
7. Yusuf N, Irby C, Katiyar SK, Elmets CA. Photoprotective effects of green tea polyphenols. Photodermatol Photoimmunol Photomed 2007; 23: 48-56.
8. Tamura T, Fuji A, Kuboyama N. Effects of royal jelly on experimental transplantable tumours. In: Proceeding of the XXXth International Congress on Apiculture; Nagoya, Japan. Bucharest: Apimondia Publishing House; 1985, p. 474-477.
9. Cragg GM, Newman DJ. Nature, a vital source of leads for anticancer drug development. Phytochem Rev 2009; 8: 313-331.
10. Pichichero E, Canuti L, Canini A. Characterisation of the phenolic and flavonoid fractions and antioxidant power of Italian honeys of different botanical origin. J Sci Food Agric 2009; 89: 609-616.
11. Aljadi AM, Kamaruddin MY. Evaluation of the phenolic contents and antioxidant capacities of two Malaysian floral honeys. Food Chem 2004; 85: 513-518.
12. Al-Mamary M, Al-Meeri A, Al-Habori M. Antioxidant activities and total phenolics of different types of honey. Nutr Res 2002; 22: 1041-1047.
13. Gheldof N, Wang XH, Engeseth NJ. Identification and quantification of antioxidant components of honeys from various floral sources. J Agric Food Chem 2002; 50: 5870-5877.
14. Sabatier S, Amiot MJ, Tacchin M, Aubert S. Identification of flavonoids in sunflower honey. J Food Sci 1992; 57: 773-774.
15. Yao LH, Datta N, Tomas-Barberan FA, Ferreres F, Martos I, Singanusong R. Flavonoids, phenolic acids and abscisic acid in Australian and New Zealand Leptospermum honeys. Food Chem 2003; 81: 159-168.
16. Estevinho L, Pereira A, Moreira L, Dias LG, Pereira E. Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey. Food Chem Toxicol 2008; 46: 3774-3779.
17. Middleton CO, Harbored EJ. Plant flavonoid in biology and medicine-biochemical, pharmacological and structure-activity relationships. Cody V, Middleton E, Harborne JB, editors. New Jersey: John Wiley&Sons Inc; 1986, p. 28.
18. Woo KJ, Jeong YJ, Park JW, Kwon TK. Chrysin-induced apoptosis is mediated through capase activation and Akt inactivation in U937 leukemia cells. Biochem Biophys Res Commun 2004; 325: 1215-1222.
19. Tonks A, Cooper RA, Price AJ, Molan PC, Jones KP. Stimulation of TNK-alpha release in monocytes by honey. Cytokine 2001; 14: 240-242.
20. Jaganathan SK, Mandal M. Involvement of non-protein thiols, mitochondrial dysfunction, reactive oxygen species and p53 in honey-induced apoptosis. Invest New Drugs 2010; 28: 624-633.
21. Pichichero E, Cicconi R, Mattei M, Muzi MG, Canini A. Acacia honey and chrysin reduce proliferation of melanoma cell through alterations in cell cycle progression. Int J Oncol 2010; 37: 973-981.
22. Samarghandian S, Afshari JT, Davoodi S. Honey induces apoptosis in renal cell carcinoma. Pharmacogn Mag 2011; 7(25): 46-52.
23. Dustmann JH. Antibacterial effect of honey. Apiacta 1979; 14: 7-11.
24. Brudzynski K. Effect of hydrogen peroxide on antibacterial activities of Canadian honeys. Can J Microbiol 2006; 52: 1228-1237.
25. Jeddar A, Khassany A, Ramsaroop VG, Bhamjei A, Haffejee IE, Moosa A. The antibacterial action of honey: an in vitro study. S Afr Med J 1985; 67: 257-258.
26. Fukuda M, Kobayashi K, Hirono Y, Miyagawa M, Ishida T, Ejiogu EC, et al. Jungle honey enhances immune function and antitumor activity. Evid Based Complement Alternat Med 2011; 2011: 908743.
27. Fauzi AN, Norazmi MN, Yaacob NS. Tualang honey induces apoptosis and disrupts the mitochondrial membrane potential of human breast and cervical cancer cell lines. Food Chem Toxicol 2011; 49(4): 871-878.
28. Ghashm AA, Othman NH, Khattak MN, Ismail NM, Saini RN. Antiproliferative effect of Tualang honey on oral squamous cell carcinoma and osteosarcoma cell lines. BMC Compl Alternative Med 2010; 10: 49.
29. Gribel NV, Pashiniski VG. [The antitumor properties of honey]. Vopr Onkol 1990; 36: 704-709. Russian.
30. Nada O, Ivan B. Honey as a cancer-preventive agent. Period Biol 2004; 106: 397-401.
31. Orsolic N, Terzic S, Sver L, Basic I. Honey-bee products in prevention and/or therapy of murine transplantable tumours. J Sci Food Agric 2005; 85: 363-370.
32. Wattenberg LW. Chemoprevention of cancer by naturally occurring and synthetic compounds. Wattenberg L, Lipkin M, Boone CW, Kellof GJ, editors. Cancer chemoprevention. Boca Ranton: CRC Press; 1992, p. 19-40.
33. Heuson JC, Legros N, Heimann R. Influence of insulin administration on growth of the 7,12-dimethylbenzanthraceneinduced mammary carcinoma in intact, oophorectmized, and hypophysectomized rats. Cancer Res 1972; 32: 233-238.
34. Moutsatsou P. The spectrum of phytoestrogens in nature: Our knowledge is expanding. Hormones (Athens) 2007; 6: 173-193.
35. Othman NH. Honey and cancer: sustainable inverse relationship particularly for developing nations-a review. Evid Based Complement Alternat Med 2012; 2012(2012): 410406.
36. Rao CV, Desai D, Simi B, Kulkarni N, Amin S, Reddy BS. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res 1993; 53: 4182-4188.
37. Abuharfeil N, Al-Oran R, Abo-Shehada M. The effect of bee honey on the proliferative activity of human B-and T-lymphocytes and the activity of phagocytes. Food Agri Immun 1999; 11: 169-177.
38. Rady H. Phytochemical and biological study of an antitumor agent of plant origin mixed with honey on malignant human cells in vitro. [dissertation]. Cairo: Faculty of Science. Cairo University; 2005.
39. Tonks AJ, Cooper RA, Jones KP, Blair S, Parton J, Tonks A. Honey stimulates inflammatory cytokine production from monocytes. Cytokine 2003; 21: 242-247.
40. Al-Waili NS, Haq A. Effect of honey on antibody production against thymus-dependent and thymus-independent antigens in primary and secondary immune responses. J Med Food 2004; 7: 491-494.
41. Gheldof N, Engeseth NJ. Antioxidant capacity of honeys from various floral sources based on the determination of oxygen radical absorbance capacity and inhibition of in vitro lipoprotein oxidation in human serum samples. J Agri Food Chem 2002; 50(10): 3050-3055.
42. Von Low EC, Perabo FG, Siener R, Muller SC. Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data. In vivo 2007; 21: 189-204.
43. Pietta PG, Gardana C, Pietta AM. Analytical methods for quality control of propolis. Fitoterapia 2002; 73: S7-20.
44. Kuropatnicki AK, Szliszka E, Krol W. Historical aspects of propolis research in modern times. Evid Based Complement Alternat Med 2013; 2013: 964149.
45. Farooqui T, Farooqui AA. Molecular mechanism underlying the therapeutic activities of propolis: a critical review. Curr Nutr Food Sci 2010; 6: 186-199.
46. Bankova VS, Popov SS, Marekov NL. High performance liquid chromatographic analysis of flavonoids from propolis. J Chromatography A 1982; 242: 135-143.
47. Bankova VS, Popov SS, Marekov NL. A study on flavonoids of propolis. J Nat Prod 1983; 46: 471-474.
48. Bankova V, Popov S, Marekov N, Manolova N, Maksimova V. [The chemical composition of some propolis fractions with antiviral action]. Acta Microbiol Bulg 1988; 23: 52-57. Bulgarian.
49. Polyakov VV, Shukenova RZH, Orlov VK. Fatty acids in propolis. Pchelovodstvo 1988; 10: 30.
50. Kimoto T, Aga M, Hino K, Koya-Miyata S, Yamamoto Y, Micallef MJ, et al. Apoptosis of human leukemia cells induced by artepillin C, an active ingredient of Brazilian propolis. Anticancer Res 2001; 21: 221-228.
51. Kimoto T, Arai S, Kohguchi M, Aga M, Nomura Y, Micallef MJ, et al. Apoptosis and suppression of tumour growth by artepillin C extracted from Brazilian propolis. Cancer Detect Prevent 1998; 22: 506-515.
52. Kimoto T, Koya-Miyata S, Hino K, Micallef MJ, Hanaya T, Arai S, et al. Pulmonary carcinogenesis induced by ferric nitrilotriacetate in mice and protection from it by Brazilian propolis and artepillin C. Virchows Arch 2001; 438: 259-270.
53. Scheller S, Krol W, Swiacik J, Owczarek S, Gabrys J, Shani J. Antitumoral property of ethanolic extract of propolis in micebearing Ehrlich carcinoma, as compared to bleomycin. Z Naturforsch C 1989; 44(11-12): 1063-1065.
54. Femia AP, Caderni G, Buzzigoli C, Cocca E, Salvadori M, Dolara P. Effect of simple phenolic compounds on azoxymethane-induced aberrant crypt foci in rat colon. Nutr Cancer 2001; 41: 107-110.
55. Galati G, Teng S, Moridani MY, Chan TS, O'Brien PJ. Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metabol Drug Interact 2000; 17: 311-349.
56. Sudlina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993; 329: 21-24.
57. Piantelli M, Maggiano N, Ricci R, Larocca LM, Cappelli A, Scambia G, et al. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. J Invest Dermatol 1995; 105: 248-253.
58. Chen CN, Wu CL, Lin JK. Propolin C from propolis induces apoptosis through activating caspases, Bid and cytochrome C release in human melanoma cells. Biochem Pharmacol 2004; 67: 53-66.
59. Luo J, Soh JW, Xing WQ, Mao Y, Matsuno T, Weinstein IB. PM-3, a benzo-gamma-pyran derivative isolated from propolis, inhibits growth of MCF-7 human breast cancer cells. Anticancer Res 2001; 21: 1665-1671.
60. Reed JC. Mechanism of apoptosis. Am J Pathol 2000; 157: 1415-1430.
61. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome C by the mitochondrial channel VDAC. Nature 1999; 399: 483-487.
62. Mouse HA, Tilaoui M, Jaafari A, M'Barek LA, Aboufatima R, Chait A, et al. Evaluationof the in vitro and in vivo anticancer properties of Moroccan propolis extracts. Rev Bras Farmacogn 2012; 22: 558-567.
63. Kumazawa S, Hamasaka T, Nakayama T. Antioxidant activity of propolis of various geographic origins. Food Chem 2004; 84: 329-339.
64. Orsolic N, Basic I. Immunomodulation by water-soluble derivative of propolis: a factor of antitumor reactivity. J Ethnopharmacol 2003; 84: 265-273.
65. Orsolic N, Knezevic AH, Sver L, Terzic S, Basic I. Immunomodulatory and antimetastatic action of propolis and related polyphenolic compounds. J Ethnopharmacol 2004; 94: 307-315.
66. Aso K, Kanno S, Tadano T, Satoh S, Ishikawa M. Inhibitory effect of propolis on the growth of human leukemic U937. Biol Pharm Bull 2004; 27: 727-730.
67. Lirdprapamongkol K, Sakurai H, Abdelhamed S, Yokoyama S, Athikomkulchai S, Viriyaroj A, et al. Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation. Int J Oncol 2013; 43(1): 329-337.
68. Lee YJ, Liao PH, Chen WK, Yang CC. Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells. Cancer Lett 2000; 153: 51-56.
69. Lee YJ, Kuo HC, Chu CY, Wang CJ, Lin WC, Tseng TH. Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochem Pharmocol 2003; 66: 2281-2289.
70. Hung MW, Shiao MS, Tsai LC, Chang GG, Chang TC. Apoptotic effect of caffeic acid phenenyl ester and its ester and amide analogues in human cervical cancer ME180 cells. Anticancer Res 2003; 23: 4773-4780.
71. McEleny K, Coffey R, Morrissey C, Fitzpatrick JM, Watson RW. Caffeic acid phenethyl ester-induced PC-3 cell apoptosis is caspase-dependent and mediated through the loss of inhibitors of apoptosis proteins. BJU Int 2004; 94: 402-406.
72. Lapidot T, Walker MD, Kanner J. Antioxidant and prooxidant effects of phenolics on pancreatic beta-cells in vitro. J Agric Food Chem 2002; 50: 7220-7225.
73. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E, et al. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 1999; 18: 6845-6854.
74. Weber WW, Hein DW. N-acetylation phamacogenetics. Pharmacol Rev 1985; 37: 25-79.
75. Hirvonen A. Polymorphic NATs and cancer predisposition. IARC Sci Publ 1999; (148): 251-270.
76. Roger A, Rubira N, Nogueiras C, Guspi R, Baltasar M, Cadahia A. [Anaphylaxis caused by royal jelly]. Allergol Immunopathol 1995; 23: 133-135. Spanish.
77. Guo H, Saiga A, Sato M, Miyazawa I, Shibata M, Takahata Y, et al. Royal jelly supplementation improves lipoprotein metabolism in humans. J Nutr Sci Vitaminol (Tokyo) 2007; 53: 345-348.
78. Shen X, Lu R, He G. [Effects of lyophilized royal jelly on experimental hyperlipidemia and thrombosis]. Zhonghua Yu Fang Yi Xue Za Zhi 1995; 29: 27-29. Chinese.
79. Kimura Y. Antitumor and antimetastatic actions of various natural products. Stud Nat Prod Chem 2008; 34: 35-76.
80. Chung JG. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rat. Toxicol Sci 1999; 51: 202-210.
81. Habermann E. Bee and wasp venoms: the biochemistry and pharmacology of their peptides and enzymes are reviewed. Science 1972; 177: 314-322.
82. Raghuraman H, Chattopadhyay A. Melittin: a membrane-active peptide with diverse functions. Biosci Rep 2007; 27: 189-223.
83. Liu X, Chen D, Xie L, Zhang R. Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B16 melanomas in-vivo. J Pharm Pharmacol 2002; 54: 1083-1089.
84. Orsolic N, Knezevic A, Sver L, Terzic S, Hackenberger BK, Basic I. Influence of honey bee products on transplantable murine tumors. Vet Comp Oncol 2003; 1: 216-226.
85. Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther 2007; 115: 246-270.
86. Orsolic N, Sver L, Verstovsek S, Terzic S, Basic I. Inhibition of mammary carcinoma cell proliferation in vitro and tumour growth in vivo by bee venom. Toxicon 2003; 41: 861-870.
87. Jang MH, Shin MC, Lim S, Han SM, Park HJ, Shin I, et al. Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCIH1299. J Pharmacol Sci 2003; 91: 95-104.
88. Basic I, Varga E. Immunogenicity of a mammary carcinoma and a fibrosarcoma of CBA mice. Period Biol 1979; 81: 335-337.
89. Orsolic N, Sver L, Terzic S, Tadic Z, Basic I. Inhibitory effect of water-soluble derivative of propolis (WSDP) and its polyphenolic compounds on tumour growth and metastasing ability: a possible mode of antitumour action. Nutr Cancer 2003; 47: 156-163.
90. Moon DO, Park SY, Heo MS, Kim KC, Park C, Ko WS, et al. Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt. Int Immunopharmacol 2006; 6: 1796-1807.
91. Hong S-J, Gyu SR, Hyung IY, Chang SY, Hyeong GK, Jang MH, et al. Bee venom induces apoptosis through caspase-3 activation in synovial fibroblasts of patients with rheumatoid arthritis. Toxicon 2005; 46: 39-45.
92. Six DA, Dennis EA. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 2000; 1488: 1-19.
93. Wade D, Boman A, Wahlin B, Drain CM, Andreu D, Boman HG, et al. All-D amino acid-containing channel-forming antibiotic peptides. Proc Natl Acad Sci USA 1990; 87: 4761-4675.
94. Carrasquer G, Li M, Yang S, Schwartz M. Effect of melittin on PD, resistance and short-circuit current in the frog gastric mucosa. Biochim Biophys Acta 1998; 1369: 346-354.
95. Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 2008; 1778: 357-375.
96. Chu ST, Cheng HH, Huang CJ, Chang HC, Chi CC, Su HH, et al. Phospholipase A2-independent Ca2+ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells. Life Sci 2007; 80: 364-369.
97. Wang C, Chen T, Zhang N, Yang M, Li B, Lu X, et al. Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosisinducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IkBa kinase-NFkappaB. J Biol Chem 2009; 284: 3804-3813.
98. Park JH, Jeong YJ, Park KK, Cho HJ, Chung IK, Min KS, et al. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kB and AP-1-dependent MMP-9 expression. Mol Cells 2010; 29: 209-215.
99. Fukushima N, Kohno M, Kato T, Kawamoto S, Okuda K, Misu Y, et al. Melittin, a metabostatic peptide inhibiting Gs activity. Peptides 1998; 19: 811-819.
100. Sharma SV. Melittin resistance: a counter selection for ras transformation. Oncogene 1992; 7: 193-201.
101. Zhu HG, Tayeh I, Israel L, Castagna M. Different susceptibility of lung cell lines to inhibitors of tumor promotion and inducers of differentiation. J Biol Regul Homeost Agents 1991; 5: 52-58.
102. Wu YL, Jiang XR, Newland AC, Kelsey SM. Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. J Immunol 1998; 160: 5929-5935.
103. Engers R, Gabbert HE. Mechanisms of tumor metastasis: Cell biological aspects and clinical implications. J Cancer Res Clin Oncol 2000; 126: 682-692.